“Rather than new legislative proposals, we can achieve our objectives by better implementing and enforcing existing legislation while using incentives and new market-based tools to promote change,” Hansen said in reply to a question on whether the EU’s executive would propose the framework next year. Costas Kadis Cyprus’ Costas Kadis, the commissioner candidate for fisheries … Read more
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. CEO Adam Steensberg told CNBC Thursday that early-stage trials of its experimental obesity injection point to higher-quality weight loss — with reduced muscle loss and fewer side effects — … Read more
WALTHAM, Mass., Sept. 10, 2024 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved efficacy and convenience in the treatment of Inflammatory Bowel Disease (“IBD”), today announced that management will participate in a fireside chat and investor meetings at … Read more
TEMPE, Ariz. and MEXICO CITY, Aug. 2, 2024 /PRNewswire/ — To support the growing needs of the global supply chain management community, Institute for Supply Management® (ISM®) will expand its offerings in Mexico and Latin America as of September 2024. This will include providing supply chain skill-building courses, ISM certification preparation programs, and executive-level events. … Read more
The 2023 bull market, led by large-cap tech stocks, changed momentum this year to benefit smaller companies due to several economic trends, like the slowing rate of inflation growth that is driving up bets on a September rate cut by the US Federal Reserve. According to TipRanks, Goldman Sachs chief US equity strategist David Kostin … Read more
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk’s blockbuster Wegovy weight loss drug has received backing from the European Union’s medical regulator to expand the medicine’s use to include reducing the rise of serious heart events in overweight and obese adults. The Danish … Read more
ROCKVILLE, Md. and SUZHOU, China, July 3, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to the Exclusive Option Agreement with Takeda for the third-generation BCR-ABL inhibitor olverembatinib (HQP1351), Ascentage Pharma has … Read more
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world’s second largest economy. China’s National Medical Products Administration “recently” … Read more
The S & P 500 and Nasdaq extended their record rallies this week following cooler-than-expected consumer inflation data Wednesday morning. While Fed rate cuts would likely benefit the overall stock market, several names in the CNBC Investing Club portfolio — from housing plays to autos to biotech — could really get a boost. Connecting the … Read more
MUMBAI: Prof. Rintu Banerjee has been appointed the new Deputy Director of IIT Kharagpur, making her the first woman to hold this position at the first IIT in the country and the world. She is the Founding Head and current Chairperson of the P.K. Sinha Centre for Bioenergy and Renewables and has served as the … Read more
